Diagnosis of Hypersensitivity Pneumonitis: 2020 Clinical Practice Guideline
- Author:
Soojung PARK
1
;
Yu-Whan OH
;
Eun-Young KANG
;
Hwan Seok YONG
;
Cherry KIM
;
Ki Yeol LEE
;
Sung Ho HWANG
Author Information
- Publication Type:Review Article
- From:Journal of the Korean Radiological Society 2021;82(4):817-825
- CountryRepublic of Korea
- Language:English
- Abstract: Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) characterized by an inhaled inciting antigen that leads to the inflammation of the lung parenchyma and small airway with immunologic reactions. Over the last decades, the most effective therapeutic option for HP has been limited to antigen avoidance. The differential diagnosis of HP from other ILDs is the beginning of treatment as well as diagnosis. However, the presence of several overlapping clinical and radiologic features makes differentiating HP from other ILDs particularly challenging. In 2020, a multidisciplinary committee of experts from the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax suggested a new clinical practice guideline classifying HP into nonfibrotic and fibrotic phenotypes on the basis of chest high-resolution CT (HRCT) findings. Therefore, we introduced a new diagnostic algorithm based on chest HRCT in the clinical practice guideline for the diagnosis of HP.
